Advanced search
Publication Cover
Cancer Investigation Volume 23, 2005 - Issue 1
Submit an article Journal homepage
63
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Phase II Study of Weekly Low-Dose Paclitaxel for Relapsed and Refractory Non-Hodgkin's Lymphoma: A Wisconsin Oncology Network Study

Brad S. Kahl Department of Medicine, University of Wisconsin Comprehensive Cancer Center, University of Wisconsin Medical School, 600 Highland Avenue, H4/534 CSC, Madison, Wisconsin, 53792, USA; Department of Medicine, University of Wisconsin Comprehensive Cancer Center, University of Wisconsin Medical School, 600 Highland Avenue, H4/534 CSC, Madison, WI, 53792, USA
, M.D.,
Howard H. Bailey Department of Medicine, University of Wisconsin Comprehensive Cancer Center, University of Wisconsin Medical School, 600 Highland Avenue, H4/534 CSC, Madison, Wisconsin, 53792, USA
,
Kyung-Mann Kim Department of Biostatistics, University of Wisconsin Comprehensive Cancer Center, University of Wisconsin Medical School, 600 Highland Avenue, H4/534 CSC, Madison, Wisconsin, 53792, USA
,
Eileen P. Smith Department of Medicine, University of Wisconsin Comprehensive Cancer Center, University of Wisconsin Medical School, 600 Highland Avenue, H4/534 CSC, Madison, Wisconsin, 53792, USA
,
Nancy Turman Department of Medicine, University of Wisconsin Comprehensive Cancer Center, University of Wisconsin Medical School, 600 Highland Avenue, H4/534 CSC, Madison, Wisconsin, 53792, USA
,
Jamie Smith Department of Medicine, University of Wisconsin Comprehensive Cancer Center, University of Wisconsin Medical School, 600 Highland Avenue, H4/534 CSC, Madison, Wisconsin, 53792, USA
,
Jae Werndli Department of Medicine, University of Wisconsin Comprehensive Cancer Center, University of Wisconsin Medical School, 600 Highland Avenue, H4/534 CSC, Madison, Wisconsin, 53792, USA
,
James McGovern Green Bay Oncology, Green Bay, WisconsinUSA
,
Alcee Jumonville Gundersen Lutheran Hospital, LaCrosse, WisconsinUSA
,
Eliot C. Williams Department of Medicine, University of Wisconsin Comprehensive Cancer Center, University of Wisconsin Medical School, 600 Highland Avenue, H4/534 CSC, Madison, Wisconsin, 53792, USA
&
Walter L. Longo Department of Medicine, University of Wisconsin Comprehensive Cancer Center, University of Wisconsin Medical School, 600 Highland Avenue, H4/534 CSC, Madison, Wisconsin, 53792, USA
 show all
Pages 13-18 | Published online: 11 Jun 2009

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (7)

Yan Qin, Shiyu Jiang, Peng Liu, Jianliang Yang, Sheng Yang, Xiaohui He, Shengyu Zhou, Lin Gui, Jing Lin, Xinhua Du, Yuting Yi, Yan Sun & Yuankai Shi. (2020) Characteristics and Management of TP53-Mutated Diffuse Large B-Cell Lymphoma Patients. Cancer Management and Research 12, pages 11515-11522.
Read now
Liang Wang, Xiao-qin Chen & Zhong-jun Xia. (2020) New tricks for old drugs: combination of rituximab and two nanoparticle-delivered chemotherapy drugs, albumin-bound paclitaxel and pegylated liposomal doxorubicin, in the treatment of relapsed/refractory diffuse large B cell lymphoma. Leukemia & Lymphoma 61:10, pages 2502-2506.
Read now
Sagun Goyal, Eunhye Oak, Jingqin Luo, Amanda F. Cashen, Kenneth Carson, Todd Fehniger, John DiPersio, Nancy L. Bartlett & Nina D. Wagner-Johnston. (2018) Minimal activity of nanoparticle albumin-bound (nab) paclitaxel in relapsed or refractory lymphomas: results of a phase-I study. Leukemia & Lymphoma 59:2, pages 357-362.
Read now
Vincent Camus & Hervé Tilly. (2017) Managing early failures with R-CHOP in patients with diffuse large B-cell lymphoma. Expert Review of Hematology 10:12, pages 1047-1055.
Read now
Sagar Lonial, Martha Arellano, Donald Hutcherson, Amelia Langston, Christopher Flowers, L. T. Heffner$suffix/text()$suffix/text(), Elliott Winton, Mary Jo Lechowicz & Edmund K. Waller. (2006) Results of a clinical phase I dose-escalation study of cytarabinein combination with fixed-dose vinorelbine, paclitaxel, etoposideand cisplatin for the treatment of relapsed/refractory lymphoma. Leukemia & Lymphoma 47:10, pages 2155-2162.
Read now
Adam Lerner & Nancy Andrea. (2005) Vinca Alkaloids vs. Taxanes as Therapy in Lymphoid Malignancies: Do Our Experimental Models Obscure Our Understanding of How These Drugs Really Work?. Cancer Investigation 23:1, pages 100-102.
Read now
Mitchell Smith & Hossein Borghaei. (2005) Comment on “Phase II Study of Weekly Low-Dose Paclitaxel for Relapsed and Refractory Non-Hodgkin's Lymphoma: A Wisconsin Oncology Network Study,” by Kahl et al., Cancer Investig.igation, 2005, 23(1), pp. 13–18. Cancer Investigation 23:6, pages 572-572.
Read now

Articles from other publishers (7)

Shiyu Jiang, Yan Qin, Peng Liu, Jianliang Yang, Sheng Yang, Xiaohui He, Shengyu Zhou, Lin Gui, Changgong Zhang, Liqiang Zhou, Yan Sun & Yuankai Shi. (2019) A prognostic nomogram constructed for relapsed or refractory diffuse large B‐cell lymphoma patients. Asia-Pacific Journal of Clinical Oncology 18:2.
Crossref
Randy Bowen, Andrew Hahn, Thomas Butler & Hung Khong. (2016) Complete response to azacitidine priming and nab‑paclitaxel in non‑Hodgkin lymphoma resistant to biochemotherapy. Molecular and Clinical Oncology.
Crossref
Ann Colosia, Annete Njue, Peter C. Trask, Robert Olivares, Shahnaz Khan, Adeline Abbe, Rachel Police, Jianmin Wang, Rodrigo Ruiz-Soto, James A. Kaye & Farrukh Awan. (2014) Clinical Efficacy and Safety in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Systematic Literature Review. Clinical Lymphoma Myeloma and Leukemia 14:5, pages 343-355.e6.
Crossref
Jane E. Churpek, Barbara Pro, Koen van Besien, Justin Kline, Kathy Conner, James L. WadeIIIIII, Fredrick Hagemeister, Theodore Karrison & Sonali M. Smith. (2013) A phase 2 study of epothilone B analog BMS‐247550 (NSC 710428) in patients with relapsed aggressive non‐Hodgkin lymphomas. Cancer 119:9, pages 1683-1689.
Crossref
Wenqing Qi, Laurence S. Cooke, Xiaobing Liu, Lisa Rimsza, Denise J. Roe, Ann Manziolli. Daniel O. Persky, Thomas P. Miller & Daruka Mahadevan. (2011) Aurora inhibitor MLN8237 in combination with docetaxel enhances apoptosis and anti-tumor activity in mantle cell lymphoma. Biochemical Pharmacology 81:7, pages 881-890.
Crossref
. (2005) Current Awareness in Hematological Oncology. Hematological Oncology 23:2, pages 82-89.
Crossref
Tamara Everington & Anthony H Goldstone. (2005) Novel Approaches to the Management of Non-Hodgkin Lymphoma. American Journal of Cancer 4:3, pages 145-158.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.